Announcements Trials
Browse Landscape

Phase

Phase NA 71Phase 2 29Phase 3 13Phase 4 7Phase 1 5Phase 2/3 4Phase 1/2 3Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Hepatic Metastasis of Colorectal Cancer 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Radiofrequency Ablation × Clear all
NCT04202978 2020-04-16

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Zhongshan Hospital Xiamen University

Phase 1/2 Unknown
23 enrolled
Gastrointestinal

Hepatic Metastasis of Colorectal Cancer

NCT00891475 2014-02-13

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Kidney Cancer Research Bureau

Phase 1/2 Completed
114 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas

Phase 1/2 Completed
32 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡